Health and Healthcare
5864 Articles
Biotehc firm Rigel’s (RIGL) rheumatoid arthritis drug candidate R788 did not meet its primary endpoint in Phase IIb clinical trial,…
Bristol Myers Inc. (NYSE: BMY) plans to spend $2.4 billion to buy partner Medarex Inc. (Nasdaq: MEDX). It will get…
The swine flue is apparently more dangerous that the garden variety of flu that has been part of the world…
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line…
The world will have 1.3 billion people over 65 by 2040, according to a new report from the US Census…
Addus HomeCare Corporation has filed to come public via an initial public offering. The company has taken the “ADUS” as…
Obama’s health care received perhaps its harshest criticism to-date Thursday, after the nonpartisan Congressional Budget Office said it will “significantly”…
Health Net Inc. (NYSE: HNT) is one of today’s worse performers on the heels of losing its Pentagon health insurance…
Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed…
Having money is not what it used to be. According to several media reports, the billionaire mayor of New York…
Here are some of the top stories affecting key drug and biotech stocks this Friday. We also have links through…
Here are some of the top stories affecting key drug and biotech stocks that have links through to more in-depth…
These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details…
Here are some of the top stories affecting key drug and biotech stocks that are covered in-depth today at BioHealthInvestor.com:…
Managed health care company stocks are rising Tuesday despite press reports that hospitals will contribute $155 billion over 10 years…
Our top personal finance-related articles today. Your wallet will thank you later.